Evolution of living donor liver transplantation in adults: a single center experience

Kiuchi, Tetsuya; Inomata, Yukihiro; Üemoto, Shinji; Asonuma, Katsuhiro; Egawa, Hiroto; Fujita, Shiro; Hayashi, Michihiro; Uryuhara, Kinji; Tanaka, Kōichi

doi:10.1111/j.1432-2277.2000.tb02002.x

Cited by 7 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pulmonary (right upper lobe) tuberculosis was 71 transplant recipients from all other regions of the world detected concomitantly in this patient's mother who had (P Å .01). This finding is likely due to the fact that nonrenal donated the segmental hepatic allograft [35]. For two renal solid organ transplant recipients with tuberculosis in this report transplant recipients, donor transmission was considered (in whom cumulative immunosuppression may be greater) were likely in light of positive tuberculin skin tests documented almost exclusively from the United States and Europe.…”

Section: Clinical Manifestationsmentioning

confidence: 81%

“…the difference in the frequency of disseminated disease between Donor transmission was considered highly probable for various organ transplant recipients was not statistically signifia pediatric recipient of a living-related lateral-segment hecant ( [35]. Pulmonary (right upper lobe) tuberculosis was 71 transplant recipients from all other regions of the world detected concomitantly in this patient's mother who had (P Å .01).…”

Section: Clinical Manifestationsmentioning

confidence: 96%

“…, a miliary polymorphism analysis documented transmission of the donor pattern in 22% (49), nodules in 15%(35), pleural effusions in M. tuberculosis strain to five renal transplant recipients. It is 13% (30), diffuse interstitial infiltrates in 5%(12), and cavitary notable that the median incubation period for tuberculosis in this lung disease in 4%(8).…”

mentioning

confidence: 98%

See 2 more Smart Citations

Mycobacterium tuberculosisInfection in Solid‐Organ Transplant Recipients: Impact and Implications for Management

1998

View full text Add to dashboard Cite

Tuberculosis is a serious opportunistic infection in transplant recipients. On the basis of the compilation of published reports in the literature, the incidence of Mycobacterium tuberculosis infection in organ transplant recipients worldwide ranged from 0.35% to 15%. Nonrenal transplantation (P = .004), rejection within 6 months before the onset of tuberculosis (P = .02) and type of primary immunosuppressive regimen (P = .007) were predictors of M. tuberculosis infection occurring within 12 months after transplantation. Thirty-three percent (155) of 476 transplant patients with tuberculosis had disseminated infection; receipt of OKT3 or anti-T cell antibodies (P = .005) was a significant predictor of disseminated tuberculosis. Overall, the mortality rate among 499 patients was 29%; disseminated infection (P = .0003), prior rejection (P = .006), and receipt of OKT3 or anti-T cell antibodies (P = .0013) were significant predictors of mortality in patients with tuberculosis. Clinically significant hepatotoxicity due to isoniazid occurred in 2.5%, 4.5%, and 41% of renal, heart and lung, and liver transplant recipients, respectively. The diagnosis and effective management of tuberculosis after transplantation warrant recognition of the unique epidemiological and clinical characteristics of tuberculosis in transplant recipients.

show abstract

Section: Clinical Manifestationsmentioning

confidence: 81%

Section: Clinical Manifestationsmentioning

confidence: 96%